These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3695489)

  • 1. Biological and biochemical characterization of estrogen-dependent mouse Leydig cell tumors.
    Sato B; Miyashita Y; Nishizawa Y; Noma K; Kishimoto S; Mori H; Matsumoto K
    J Steroid Biochem; 1987; 27(1-3):421-9. PubMed ID: 3695489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
    Sato B; Maeda Y; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
    Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of 5 alpha-products as major C19-steroids in estrogen-responsive mouse Leydig cell tumor lines.
    Takatsuka D; Mori H; Noguchi S; Nishizawa Y; Sato B; Matsumoto K
    J Steroid Biochem; 1986 Mar; 24(3):715-9. PubMed ID: 3486325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL; Huseby RA; Wilcox RB
    Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen and tamoxifen on secretory glycoprotein synthesis in mouse Leydig cell tumor in vivo.
    Nishizawa Y; Sato B; Kishimoto S; Matsumoto K
    Anticancer Res; 1988; 8(4):557-62. PubMed ID: 3178148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B; Spomer W; Huseby RA; Samuels LT
    Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of an estrogen-dependent early steroidogenic lesion in murine Leydig tumor cells.
    Zimniski SJ; Melner MH; Puett D
    Endocrinology; 1985 Jun; 116(6):2583-91. PubMed ID: 3996327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression.
    Huseby RA
    Cancer Res; 1983 Nov; 43(11):5365-78. PubMed ID: 6616470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a small molecule in mouse Leydig cell tumors which inhibits the conversion of estrogen receptor from 4S to 5S.
    Sato B; Huseby RA; Samuels LT
    Endocrinology; 1978 Feb; 102(2):545-55. PubMed ID: 743977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of estrogen receptors in various mouse Leydig cell tumor lines.
    Sato B; Huseby RA; Samuels LT
    Cancer Res; 1978 Sep; 38(9):2842-7. PubMed ID: 679191
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen binding component of mouse Leydig cell tumor: an in vitro conversion from nonreceptor to receptor-like molecule.
    Sato B; Maeda Y; Noma K; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Feb; 108(2):612-9. PubMed ID: 7449741
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen on cell proliferation and leukotriene formation in transformed mouse Leydig cells cultured under serum-free conditions.
    Nishizawa Y; Nishii K; Nishizawa Y; Koga M; Kishimoto S; Matsumoto K; Sato B
    Cancer Res; 1990 Jul; 50(13):3866-71. PubMed ID: 2354438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture.
    Nishizawa Y; Sato B; Miyashita Y; Tsukada S; Hirose T; Kishimoto S; Matsumoto K
    Endocrinology; 1988 Jan; 122(1):227-35. PubMed ID: 3275537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid hormone receptor regulation by various hormonal factors during mammary development and growth in the normal mouse.
    Muldoon TG
    Ann N Y Acad Sci; 1986; 464():17-36. PubMed ID: 3524349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.